Concord Biotech Ltd. NSE: CONCORDBIO | BSE: 543960

Expensive Performer

Download real time

1803.30 -5.20 (-0.29%)

32.31% Fall from 52W High

130.1K

NSE+BSE Volume

NSE 11 Jul, 2025 3:31 PM (IST)

Concord Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Concord Biotech Ltd. on BSE

Search Inside the pdf :

Concord Biotech Ltd.

08 Jul 2025

1803.30

-0.29%

Company Update

Concord Biotech Ltd - 543960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Enclosed herewith the certificate under Regulation 74(5) of the SEBI(DP) Regulations,2018 for the quarter ended 30.06.2025

Concord Biotech Ltd.

02 Jul 2025

1803.30

-0.29%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Concord Biotech Limited has made Investment of USD 1500 in Stellon Biotech Inc.

Concord Biotech Ltd.

25 Jun 2025

1803.30

-0.29%

SAST

Concord Biotech Ltd - 543960 - Closure of Trading Window

BSE India

Intimation of Trading Window closure

Concord Biotech Ltd.

24 Jun 2025

1803.30

-0.29%

Company Update

Concord Biotech Ltd - 543960 - Update On The USFDA Inspection At The Company''s API Facility …

BSE India

Concord Biotech limited receives Establishment Inspection Report (EIR) for it''s API facility at Dholka

Concord Biotech Ltd.

06 Jun 2025

1803.30

-0.29%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Transcript of Earnings Conference Call held on 30th May 2025

Concord Biotech Ltd.

02 Jun 2025

1803.30

-0.29%

Company Update

Concord Biotech Ltd - 543960 - Intimation Pursuant To Regulation 30(5) Of The Securities And Exchange …

BSE India

Disclosure under Regulation 30(5) of SEBI (LODR) Regulations,2015, Authorization for determining Materiality of Events and Information.

Concord Biotech Ltd.

02 Jun 2025

1803.30

-0.29%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 scheduled on 10th June, 2025 at 09:00 AM

Concord Biotech Ltd.

02 Jun 2025

1803.30

-0.29%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 scheduled on 09th June, 2025 at 10:00 AM

Concord Biotech Ltd.

31 May 2025

1803.30

-0.29%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publications of Financial Results Q4 & FY25

Concord Biotech Ltd.

30 May 2025

1803.30

-0.29%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated May 27, 2025 to the Stock exchanges regarding Earning call in respect of the Audited (Standalone and Consolidated) Financial Results of the company for quarter and year ended March 31, 2025, we wish to inform that the said Earning Call was held today at 02:30 PM (IST).